 |
|
|
| |
HIGH EFFICACY OF RETREATMENT WITH LEDPASVIR AND SOFOSBUVIR IN HCV PATIENTS WHO FAILED INITIAL SHORT COURSE THERAPY WITH COMBINATION DAA REGIMENS (NIH SYNERGY TRIAL)
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Eleanor M. P. Wilson* 1, 2, Sarah Kattakuzhy3, Zayani Sims1, Lydia Tang3, Mary McLaughlin4, Angie Price3, Rachel Silk3, Chloe Gross3, Elizabeth Akoth3, Anu Osinusi5, Henry Masur1, Anita Kohli1, Shyam Kottilil3
1Critical Care Medicine Department, National Institutes of Health, Bethesda, MD, 2Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick, MD, 3Department of Infectious Diseases, University of
Maryland/Institute of Human Virology, Baltimore, MD, 4National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 5Gilead Sciences, Foster City, CA, United States
|
| |
|
|
|
|
|
